AbClon

174900 · KOSDAQ · Health Care · SMALL CAP

Updated contract terms.

AbClon updated a previously disclosed supply contract, now worth US$230K, about 7.5% of its recent annual revenue, running through Aug 2026.

Supply contract([Amended] Supply contract signed (voluntary))· FILED 2026-06-30· RCEPT 20260630900653

US$230KContract value
7.5%vs. recent revenue
Aug 2026Throughfrom Apr 2026

Converted at 1 USD ≈ ₩1,548.61 (filing-date rate, 2026-06-30 close)

A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-08-31) →

What happened

AbClon updated a previously disclosed supply contract, now worth US$230K, about 7.5% of its recent annual revenue, running through Aug 2026.

For context, this single contract equals about 7.5% of the company's most recent annual revenue.

CounterpartyDisclosed
Contract valueUS$230K
vs. recent revenue7.5%
ThroughAug 2026 (from Apr 2026)
Filed2026-06-30, [Amended] Supply contract signed (voluntary)
SourceDART rcept 20260630900653 → open original filing

Versions of this filing

  1. 2026-04-07Original
  2. 2026-04-16Amendment 1
  3. 2026-06-30Amendment 2 (this page)
  4. 2026-08-31Amendment 3

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-30 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.